Amara S, Pasumarthi A, Parikh N, Kodali N, Lebwohl M, Monks G (2025) Psoriasis management tree based on comorbidity. Int J Dermatol 64:229–245. https://doi.org/10.1111/ijd.17497

Article  PubMed  Google Scholar 

Fernandez-Figueras MT, Puig L (2024) Histopathological diagnosis of psoriasis and psoriasiform dermatitides. Diagn Histopathol 31:87–97. https://doi.org/10.1016/j.mpdhp.2024.11.005

Article  Google Scholar 

Elkhawaga OY, Ellety MM, Mofty SO, Ghanem MS, Mohamed AO (2023) Review of natural compounds for potential psoriasis treatment. Inflammopharmacology 31:1183–1198. https://doi.org/10.1007/s10787-023-01178-0

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lee HJ, Kim M (2023) Challenges and future trends in the treatment of psoriasis. Int J Mol Sci 24:13313. https://doi.org/10.3390/ijms241713313

Article  PubMed  PubMed Central  CAS  Google Scholar 

Yi X, Jiang XJ, Fang ZM (2019) Histone methyltransferase SMYD2: ubiquitous regulator of disease. Clin Epigenetics 11:112. https://doi.org/10.1186/s13148-019-0711-4

Article  PubMed  PubMed Central  Google Scholar 

Zeng Y, Qiu R, Yang Y, Gao T, Zheng Y, Huang W et al (2019) Regulation of EZH2 by SMYD2-mediated lysine methylation is implicated in tumorigenesis. Cell Rep 29:1482–1498e4. https://doi.org/10.1016/j.celrep.2019.10.004

Article  PubMed  CAS  Google Scholar 

Wu W, Wang J, Xiao C, Su Z, Su H, Zhong W et al (2021) SMYD2-mediated TRAF2 methylation promotes the NF-κB signaling pathways in inflammatory diseases. Clin Transl Med 11:e591. https://doi.org/10.1002/ctm2.591

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhao Z, Yang X (2024) Inhibition of SMYD2 attenuates paraquat-induced pulmonary fibrosis by inhibiting the epithelial–mesenchymal transition through the GLIPR2/ERK/p38 axis. Pestic Biochem Physiol 202:105971. https://doi.org/10.1016/j.pestbp.2024.105971

Article  PubMed  CAS  Google Scholar 

Xu G, Liu G, Xiong S, Liu H, Chen X, Zheng B (2015) The histone methyltransferase SMYD2 is a negative regulator of macrophage activation by suppressing interleukin-6 and tumor necrosis factor-α production. J Biol Chem 290:5414–5423. https://doi.org/10.1074/jbc.M114.610345

Article  PubMed  PubMed Central  CAS  Google Scholar 

Romhányi D, Bessenyei Á, Szabó K, Kemény L, Gyulai R, Groma G (2025) Unveiling the role of histone methyltransferases in psoriasis pathogenesis: insights from transcriptomic analysis. Int J Mol Sci 26:6329. https://doi.org/10.3390/ijms26136329

Article  PubMed  PubMed Central  CAS  Google Scholar 

Dorna D, Grabowska A, Paluszczak J (2025) Natural products modulating epigenetic mechanisms by affecting histone methylation/demethylation: targeting cancer cells. Br J Pharmacol 182:2137–2158. https://doi.org/10.1111/bph.16237

Article  PubMed  CAS  Google Scholar 

Müller A, Dickmanns A, Resch C, Schäkel K, Hailfinger S, Dobbelstein M et al (2020) The CDK4/6–EZH2 pathway is a potential therapeutic target for psoriasis. J Clin Invest 130:5765–5781. https://doi.org/10.1172/JCI134217

Article  PubMed  PubMed Central  Google Scholar 

Johansen C, Mose M, Ommen P, Bertelsen T, Vinter H, Hailfinger S et al (2015) IκBζ is a key driver in the development of psoriasis. Proc Natl Acad Sci USA 112:E5825–E5833. https://doi.org/10.1073/pnas.1509971112

Article  PubMed  PubMed Central  CAS  Google Scholar 

Qu S, Liu Z, Wang B (2021) EZH2 is involved in psoriasis progression by impairing miR-125a-5p inhibition of SFMBT1 and leading to inhibition of the TGFβ/SMAD pathway. Ther Adv Chronic Dis 12:2040622320987348. https://doi.org/10.1177/2040622320987348

Article  PubMed  PubMed Central  CAS  Google Scholar 

Müller A, Hennig A, Lorscheid S, Grondona P, Schulze-Osthoff K, Hailfinger S et al (2018) IκBζ is a key transcriptional regulator of IL-36-driven psoriasis-related gene expression in keratinocytes. Proc Natl Acad Sci USA 115:10088–10093. https://doi.org/10.1073/pnas.1801377115

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhang T, Yang L, Ke Y, Lei J, Shen S, Shao S et al (2020) EZH2-dependent epigenetic modulation of histone H3 lysine-27 contributes to psoriasis by promoting keratinocyte proliferation. Cell Death Dis 11:826. https://doi.org/10.1038/s41419-020-03028-1

Article  PubMed  PubMed Central  CAS  Google Scholar 

Liu Y, Luo W, Chen S (2011) Comparison of gene expression profiles reveals aberrant expression of FOXO1, Aurora A/B and EZH2 in lesional psoriatic skins. Mol Biol Rep 38:4219–4224. https://doi.org/10.1007/s11033-010-0544-x

Article  PubMed  CAS  Google Scholar 

Sun S, Zhang X, Xu M, Zhang F, Tian F, Cui J et al (2019) Berberine downregulates CDC6 and inhibits proliferation via targeting JAK–STAT3 signaling in keratinocytes. Cell Death Dis 10:274. https://doi.org/10.1038/s41419-019-1510-8

Article  PubMed  PubMed Central  CAS  Google Scholar 

Phan C, Touvier M, Kesse-Guyot E, Adjibade M, Hercberg S, Wolkenstein P et al (2018) Association between Mediterranean anti-inflammatory dietary profile and severity of psoriasis. JAMA Dermatol 154:1017–1024. https://doi.org/10.1001/jamadermatol.2018.2127

Article  PubMed  PubMed Central  Google Scholar 

Barrea L, Balato N, Di Somma C, Macchia PE, Napolitano M, Savanelli MC et al (2015) Nutrition and psoriasis: association between disease severity and adherence to the mediterranean diet. J Transl Med 13:18. https://doi.org/10.1186/s12967-014-0372-1

Article  PubMed  PubMed Central  Google Scholar 

Korovesi A, Dalamaga M, Kotopouli M, Papadavid E (2019) Adherence to the mediterranean diet is independently associated with psoriasis risk, severity, and quality of life. Int J Dermatol 58:e164–e165. https://doi.org/10.1111/ijd.14523

Article  PubMed  Google Scholar 

Almanza-Aguilera E, Cano A, Gil-Lespinard M, Burguera N, Zamora-Ros R, Agudo A et al (2023) Mediterranean diet and Olive oil, microbiota, and obesity-related cancers. Semin Cancer Biol 95:103–119. https://doi.org/10.1016/j.semcancer.2023.08.001

Article  PubMed  CAS  Google Scholar 

Donato-Trancoso A, Correa Atella G, Romana-Souza B (2022) Dietary olive oil intake aggravates psoriatic skin inflammation in mice via Nrf2 activation. Int Immunopharmacol 108:108851. https://doi.org/10.1016/j.intimp.2022.108851

Article  PubMed  CAS  Google Scholar 

Rashid SA, Bashir S, Ullah H, Shah KU, Khan DH, Shah PA et al (2021) Methotrexate–olive oil nano-emulsion for topical application. Pak J Pharm Sci 34:205–215. https://doi.org/10.36721/PJPS.2021.34.1.SUP.205-215.1

Article  PubMed  CAS  Google Scholar 

De Stefanis D, Costelli P (2025) Extra virgin olive oil components and pro-inflammatory cytokines. Nutrients 17:2334. https://doi.org/10.3390/nu17142334

Article  PubMed  PubMed Central  CAS  Google Scholar 

Rashid SA, Bashir S, Naseem F, Farid A, Rather IA, Hakeem KR (2021) Olive oil-based methotrexate nanoemulsion gel for psoriasis. Biology (Basel) 10:1121. https://doi.org/10.3390/biology10111121

Article  PubMed  PubMed Central  CAS  Google Scholar 

Anwar MJ, Anwar MH, Imran M, Noman AM, Hussain M, Raza H, Mohamed HM, Mohamed GA, Ibrahim SRM, Yehuala TF, Alsagaby SA, Al Abdulmonem W, Abdelgawad MA, Mostafa EM, Ghoneim MM, Selim S (2025) Olive oil polyphenols: a promising approach for cancer prevention and therapy. Food Sci Nutr 13:e70976. https://doi.org/10.1002/fsn3.70976